Nuvectra Revenue Growth Rates (NVTR), Current and Historic Growth - CSIMarket
CSIMarket
 


Nuvectra Corp  (NVTR)
 

NVTR's Revenue Growth by Quarter and Year

Nuvectra's Revenue results by quarter and year




NVTR Revenue (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
4th Quarter December -
3rd Quarter September -
2nd Quarter June 12.35
1st Quarter March 11.13
FY 23.48





NVTR Revenue second quarter 2019 Y/Y Growth Comment
Nuvectra Corp reported decrease in Revenue in the second quarter 2019 by -6.12% to $ 12.35 millions, from the same quarter in 2018.
The decrease in the second quarter 2019 Nuvectra Corp's Revenue compares unfavorably to the Company's average Revenue jump of 79.97%.

Looking into second quarter 2019 results within Medical Equipment & Supplies industry 117 other companies have achieved higher Revenue growth. While Nuvectra Corp' s Revenue decline of -6.12% ranks overall at the positon no. 2956 in the second quarter 2019.




NVTR Revenue ( Y/Y Growth %) 2019
2018 2017 2016
4th Quarter December - -8.95 % 188.19 % 226.77 %
3rd Quarter September - 86.61 % 102.12 % 151.33 %
2nd Quarter June -6.12 % 82.13 % 183.14 % 117.95 %
1st Quarter March 5.3 % 109.72 % 144.66 % -
FY   - 53.36 % 154.11 % -

Financial Statements
Nuvectra's second quarter 2019 Revenue $ 12.35 millions NVTR's Income Statement
Nuvectra's second quarter 2018 Revenue $ 13.15 millions Quarterly NVTR's Income Statement


NVTR Revenue (Quarter on Quarter Growth %)

2019
2018 2017 2016
4th Quarter December - -23.42 % 56.96 % 10.08 %
3rd Quarter September - 8.14 % 5.54 % 47.84 %
2nd Quarter June 10.92 % 24.41 % 43.25 % 23.79 %
1st Quarter March 2.2 % -11.62 % 21.45 % 62.2 %
FY (Year on Year)   - 53.36 % 154.11 % -




Revenue second quarter 2019 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #118
Healthcare Sector #389
Overall #2956

Revenue Y/Y Growth Statistics
High Average Low
330.99 % 79.97 % -39.15 %
(Dec 31 2017)   (Dec 31 2018)
Revenue second quarter 2019 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #118
Healthcare Sector #389
Overall #2956
Revenue Y/Y Growth Statistics
High Average Low
330.99 % 79.97 % -39.15 %
(Dec 31 2017)   (Dec 31 2018)

Revenue by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Nuvectra's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
134.99 % 19.78 % -40.92 %
(Dec 31 2017)  


NVTR's II. Quarter Q/Q Revenue Comment
Nuvectra Corp achieved in the II. Quarter 2019 below company average Revenue rise of 10.92% quarter on quarter, to $ 12.35 millions.

Within Medical Equipment & Supplies industry 67 other companies have achieved higher Revenue quarter on quarter growth. While Nuvectra's Revenue growth quarter on quarter, overall rank is 1237.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #68
Healthcare Sector #239
Overall #1237
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #68
Healthcare Sector #239
Overall #1237
Revenue Q/Q Growth Statistics
High Average Low
134.99 % 19.78 % -40.92 %
(Dec 31 2017)  


NVTR's II. Quarter Q/Q Revenue Comment
Nuvectra Corp achieved in the II. Quarter 2019 below company average Revenue rise of 10.92% quarter on quarter, to $ 12.35 millions.

Within Medical Equipment & Supplies industry 67 other companies have achieved higher Revenue quarter on quarter growth. While Nuvectra's Revenue growth quarter on quarter, overall rank is 1237.


Nuvectra's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2019)
12 Months Ending
(Mar 31 2019)
12 Months Ending
(Dec 31 2018)
12 Months Ending
(Sep 30 2018)
12 Months Ending
(Jun 30 2018)
Cumulative Revenue 12 Months Ending $ 48.58 $ 49.38 $ 48.83 $ 49.89 $ 43.30
Y / Y Revenue Growth (TTM) 12.2 % 32.14 % 53.38 % 107.61 % 114.53 %
Year on Year Revenue Growth Overall Ranking # 101 # 135 # 239 # 120 # 100
Seqeuential Revenue Change (TTM) -1.63 % 1.13 % -2.13 % 15.24 % 15.86 %
Seq. Revenue Growth (TTM) Overall Ranking # 1434 # 730 # 538 # 248 # 229


Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jun 30 2019 period, Nuvectra's cumulative twelve months Revenue were $ 49 millions, company would post below average annual Revenue growth of 15.86% year on year, if the fiscal year would end at Jun 30 2019.
A slow-down in the Nuvectra's Revenue growth from the 37.37% growth in Mar 31 2019.

Within the Healthcare sector 32 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 101, from total ranking in previous quarter at 135.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 37
Healthcare Sector # 33
Overall # 101

Revenue TTM Y/Y Growth Statistics
High Average Low
292.81 %
113.78 %
-1.34 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 62
Sector # 231
S&P 500 # 1177
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jun 30 2019 period, Nuvectra's cumulative twelve months Revenue were $ 49 millions, company would post below average annual Revenue growth of -1.34% year on year, if the fiscal year would end at Jun 30 2019.
A slow-down in the Nuvectra's Revenue growth from the 37.37% growth in Mar 31 2019.

Within the Healthcare sector 32 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 101, from total ranking in previous quarter at 135.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 37
Healthcare Sector # 33
Overall # 101

Revenue TTM Y/Y Growth Statistics
High Average Low
292.81 %
113.78 %
-1.34 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 62
Sector # 231
S&P 500 # 1177




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
NVTR's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue rise for the quarter ending Jun 30 2019 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2019
Matinas Biopharma Holdings Inc 0.00%$ -0.001 millions
Baxter International Inc -0.07%$ -0.070 millions
Integer Holdings Corporation-0.09%$ -0.086 millions
Abbvie Inc -0.28%$ -0.278 millions
Anika Therapeutics Inc -0.43%$ -0.426 millions
Rockwell Medical inc -0.45%$ -0.453 millions
Enveric Biosciences Inc -0.55%$ -0.549 millions
Alimera Sciences Inc-0.57%$ -0.568 millions
Bio rad Laboratories Inc -0.57%$ -0.572 millions
Nature s Sunshine Products inc -0.59%$ -0.594 millions
Allergan plc-0.83%$ -0.827 millions
Zimmer Biomet Holdings Inc -0.95%$ -0.946 millions
Agenus Inc-1.13%$ -1.130 millions
Magellan Health inc -1.25%$ -1.247 millions
Sonida Senior Living Inc -1.31%$ -1.309 millions
Davita Inc -1.53%$ -1.533 millions
Enovis Corp-1.80%$ -1.798 millions
American Renal Associates Holdings Inc -1.81%$ -1.808 millions
Endo International Plc-2.09%$ -2.094 millions
Reliv International Inc-2.40%$ -2.396 millions
3m Company-2.61%$ -2.610 millions
Nevro Corp -2.61%$ -2.611 millions
Alector Inc -2.70%$ -2.701 millions
Envista Holdings Corporation-2.90%$ -2.904 millions
Amneal Pharmaceuticals Inc -2.94%$ -2.938 millions
Vivosim Labs Inc -3.05%$ -3.048 millions
Amgen Inc -3.10%$ -3.103 millions
Dentsply Sirona Inc -3.14%$ -3.138 millions
Perrigo Company Plc-3.15%$ -3.152 millions
Livanova Plc-3.59%$ -3.593 millions


About Nuvectra Revenue Growth Rates (NVTR), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.